LABP logo

Landos Biopharma (LABP) EBIT

Annual EBIT

-$22.73 M
+$17.83 M+43.97%

December 31, 2023


Summary


Performance

LABP EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherLABPprofitabilitymetrics:

Quarterly EBIT

-$9.29 M
-$2.69 M-40.62%

March 31, 2024


Summary


Performance

LABP Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherLABPprofitabilitymetrics:

TTM EBIT

-$25.54 M
-$2.82 M-12.39%

March 31, 2024


Summary


Performance

LABP TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherLABPprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

LABP EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+44.0%-78.8%-12.9%
3 y3 years+25.9%+6.1%+26.6%
5 y5 years-276.3%-165.0%-628.1%

LABP EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+78.5%+109.4%+119.4%+12.9%+131.1%
5 y5-year+72.7%+78.5%-339.4%+119.4%+628.1%+131.1%
alltimeall time+276.3%+78.5%-339.4%+119.4%+628.1%+131.1%

Landos Biopharma EBIT History

DateAnnualQuarterlyTTM
Mar 2024
-
-$9.29 M(+40.6%)
-$25.54 M(+12.4%)
Dec 2023
-$22.73 M(-44.0%)
-$6.61 M(+27.1%)
-$22.73 M(+0.4%)
Sep 2023
-
-$5.20 M(+17.1%)
-$22.63 M(-10.4%)
Jun 2023
-
-$4.44 M(-31.5%)
-$25.26 M(-21.3%)
Mar 2023
-
-$6.48 M(-0.5%)
-$32.09 M(-20.9%)
Dec 2022
-$40.56 M(+4.5%)
-$6.51 M(-16.8%)
-$40.56 M(-25.5%)
Sep 2022
-
-$7.83 M(-30.5%)
-$54.44 M(-7.8%)
Jun 2022
-
-$11.27 M(-24.7%)
-$59.02 M(+34.5%)
Mar 2022
-
-$14.95 M(-26.7%)
-$43.87 M(+13.0%)
DateAnnualQuarterlyTTM
Dec 2021
-$38.82 M(+26.5%)
-$20.40 M(+64.4%)
-$38.82 M(+30.2%)
Sep 2021
-
-$12.40 M(-419.5%)
-$29.82 M(+15.4%)
Jun 2021
-
$3.88 M(-139.2%)
-$25.84 M(-25.8%)
Mar 2021
-
-$9.90 M(-13.2%)
-$34.81 M(+13.4%)
Dec 2020
-$30.68 M(+133.0%)
-$11.40 M(+35.4%)
-$30.70 M(+34.6%)
Sep 2020
-
-$8.42 M(+65.5%)
-$22.81 M(+58.5%)
Jun 2020
-
-$5.09 M(-12.2%)
-$14.39 M(+54.7%)
Mar 2020
-
-$5.79 M(+65.2%)
-$9.30 M(+165.2%)
Dec 2019
-$13.16 M(+117.9%)
-$3.51 M
-$3.51 M
Dec 2018
-$6.04 M
-
-

FAQ

  • What is Landos Biopharma annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Landos Biopharma?
  • What is Landos Biopharma annual EBIT year-on-year change?
  • What is Landos Biopharma quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Landos Biopharma?
  • What is Landos Biopharma quarterly EBIT year-on-year change?
  • What is Landos Biopharma TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Landos Biopharma?
  • What is Landos Biopharma TTM EBIT year-on-year change?

What is Landos Biopharma annual earnings before interest & taxes?

The current annual EBIT of LABP is -$22.73 M

What is the all time high annual EBIT for Landos Biopharma?

Landos Biopharma all-time high annual earnings before interest & taxes is -$6.04 M

What is Landos Biopharma annual EBIT year-on-year change?

Over the past year, LABP annual earnings before interest & taxes has changed by +$17.83 M (+43.97%)

What is Landos Biopharma quarterly earnings before interest & taxes?

The current quarterly EBIT of LABP is -$9.29 M

What is the all time high quarterly EBIT for Landos Biopharma?

Landos Biopharma all-time high quarterly earnings before interest & taxes is $3.88 M

What is Landos Biopharma quarterly EBIT year-on-year change?

Over the past year, LABP quarterly earnings before interest & taxes has changed by -$4.10 M (-78.78%)

What is Landos Biopharma TTM earnings before interest & taxes?

The current TTM EBIT of LABP is -$25.54 M

What is the all time high TTM EBIT for Landos Biopharma?

Landos Biopharma all-time high TTM earnings before interest & taxes is -$3.51 M

What is Landos Biopharma TTM EBIT year-on-year change?

Over the past year, LABP TTM earnings before interest & taxes has changed by -$2.91 M (-12.87%)